In the study, which appeared in Science Translational Medicine on July 5, 2023, the researchers isolated T cells (a type of immune cell) from mouse and human blood samples. By analyzing the T cells that can cause type 1 diabetes, they were able to distinguish the at-risk patients who had active autoimmunity from those who had no significant autoimmunity-with 100per cent accuracy in a small sample.
